Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells

Journal of Experimental & Clinical Cancer Research

Gláucia Maria Machado-Santelli¹ 

[1] Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524, Cidade Universitária, 05508-000 São Paulo, SP, Brazil

关键词: Micronuclei;    Cytoskeleton;    Apoptosis;    Cytotoxicity;    Melanoma cells;    Cinnamic acid;   

Others  :  825054
DOI  :  10.1186/1756-9966-32-31

 received in 2013-04-29, accepted in 2013-05-17,  发布年份 2013

【 摘 要 】

Anticancer activities of cinnamic acid derivatives include induction of apoptosis by irreversible DNA damage leading to cell death. The present work aimed to compare the cytotoxic and genotoxic potential of cinnamic acid in human melanoma cell line (HT-144) and human melanocyte cell line derived from blue nevus (NGM). Viability assay showed that the IC₅₀ for HT-144 cells was 2.4 mM, while NGM cells were more resistant to the treatment. The growth inhibition was probably associated with DNA damage leading to DNA synthesis inhibition, as shown by BrdU incorporation assay, induction of nuclear aberrations and then apoptosis. The frequency of cell death caused by cinnamic acid was higher in HT-144 cells. Activated-caspase 3 staining showed apoptosis after 24 hours of treatment with cinnamic acid 3.2 mM in HT-144 cells, but not in NGM. We observed microtubules disorganization after cinnamic acid exposure, but this event and cell death seem to be independent according to M30 and tubulin labeling. The frequency of micronucleated HT-144 cells was higher after treatment with cinnamic acid (0.4 and 3.2 mM) when compared to the controls. Cinnamic acid 3.2 mM also increased the frequency of micronucleated NGM cells indicating genotoxic activity of the compound, but the effects were milder. Binucleation and multinucleation counting showed similar results. We conclude that cinnamic acid has effective antiproliferative activity against melanoma cells. However, the increased frequency of micronucleation in NGM cells warrants the possibility of genotoxicity and needs further investigation.

【 授权许可】

   
2013 Niero and Machado-Santelli; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

【 参考文献 】

• [1]Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300.
• [2]Soengas MS, Lowe SW: Apoptosis and melanoma chemoresistance. Oncogene 2003, 22(20):3138-3151.
• [3]Singh DK, Lippman SM: Cancer chemoprevention. Part 1: Retinoids and carotenoids and other classic antioxidants. Oncol (Williston Park) 1998, 12(11):1643-1653. 1657-1648; discussion 1659-1660
• [4]Singh DK, Lippman SM: Cancer chemoprevention. Part 2: Hormones, nonclassic antioxidant natural agents, NSAIDs, and other agents. Oncol (Williston Park) 1998, 12(12):1787-1800. discussion 1802, 1805
• [5]Liu L, Hudgins WR, Shack S, Yin MQ, Samid D: Cinnamic acid: a natural product with potential use in cancer intervention. Int J Cancer 1995, 62(3):345-350.
• [6]Birt DF, Pelling JC, Nair S, Lepley D: Diet intervention for modifying cancer risk. Prog Clin Biol Res 1996, 395:223-234.
• [7]Conney AH, Lou YR, Xie JG, Osawa T, Newmark HL, Liu Y, Chang RL, Huang MT: Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proc Soc Exp Biol Med 1997, 216(2):234-245.
• [8]Lee YJ, Kuo HC, Chu CY, Wang CJ, Lin WC, Tseng TH: Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. Biochem Pharmacol 2003, 66(12):2281-2289.
• [9]Ferguson LR, Philpott M, Karunasinghe N: Dietary cancer and prevention using antimutagens. Toxicology 2004, 198(1–3):147-159.
• [10]Panwar M, Kumar M, Samarth R, Kumar A: Evaluation of chemopreventive action and antimutagenic effect of the standardized Panax ginseng extract, EFLA400, in Swiss albino mice. Phytother Res 2005, 19(1):65-71.
• [11]Kuete V, Wabo HK, Eyong KO, Feussi MT, Wiench B, Krusche B, Tane P, Folefoc GN, Efferth T: Anticancer activities of six selected natural compounds of some Cameroonian medicinal plants. PLoS One 2011, 6(8):e21762.
• [12]Tang YQ, Jaganath IB, Sekaran SD: Phyllanthus spp. induces selective growth inhibition of PC-3 and MeWo human cancer cells through modulation of cell cycle and induction of apoptosis. PLoS One 2010, 5(9):e12644.
• [13]Hoskins JA: The occurrence, metabolism and toxicity of cinnamic acid and related compounds. J Appl Toxicol 1984, 4(6):283-292.
• [14]Bhimani RS, Troll W, Grunberger D, Frenkel K: Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res 1993, 53(19):4528-4533.
• [15]Jaiswal AK, Venugopal R, Mucha J, Carothers AM, Grunberger D: Caffeic acid phenethyl ester stimulates human antioxidant response element-mediated expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene. Cancer Res 1997, 57(3):440-446.
• [16]Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A: Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 2002, 132(3):552S-558S.
• [17]Mishima S, Ono Y, Araki Y, Akao Y, Nozawa Y: Two related cinnamic acid derivatives from Brazilian honey bee propolis, baccharin and drupanin, induce growth inhibition in allografted sarcoma S-180 in mice. Biol Pharm Bull 2005, 28(6):1025-1030.
• [18]Lee JM, Abrahamson JL, Kandel R, Donehower LA, Bernstein A: Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene 1994, 9(12):3731-3736.
• [19]Fukasawa K, Wiener F, Vande Woude GF, Mai S: Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene 1997, 15(11):1295-1302.
• [20]Ko LJ, Prives C: p53: puzzle and paradigm. Genes Dev 1996, 10(9):1054-1072.
• [21]Giaccia AJ, Kastan MB: The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998, 12(19):2973-2983.
• [22]Sablina AA, Ilyinskaya GV, Rubtsova SN, Agapova LS, Chumakov PM, Kopnin BP: Activation of p53-mediated cell cycle checkpoint in response to micronuclei formation. J Cell Sci 1998, 111(Pt 7):977-984.
• [23]Lanni JS, Jacks T: Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 1998, 18(2):1055-1064.
• [24]Fenech M: Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today 2002, 7(22):1128-1137.
• [25]Fenech M: Biomarkers of genetic damage for cancer epidemiology. Toxicology 2002, 181–182:411-416.
• [26]Topinka J, Sram RJ, Sirinjan G, Kocisova J, Binkova B, Fojtikova I: Mutagenicity studies on paracetamol in human volunteers. II. Unscheduled DNA synthesis and micronucleus test. Mutat Res 1989, 227(3):147-152.
• [27]Machado-Santelli GM, Cerqueira EM, Oliveira CT, Pereira CA: Biomonitoring of nurses handling antineoplastic drugs. Mutat Res 1994, 322(3):203-208.
• [28]Laffon B, Pasaro E, Mendez J: Evaluation of genotoxic effects in a group of workers exposed to low levels of styrene. Toxicology 2002, 171(2–3):175-186.
• [29]Bolognesi C, Landini E, Perrone E, Roggieri P: Cytogenetic biomonitoring of a floriculturist population in Italy: micronucleus analysis by fluorescence in situ hybridization (FISH) with an all-chromosome centromeric probe. Mutat Res 2004, 557(2):109-117.
• [30]Lewinska D, Palus J, Stepnik M, Dziubaltowska E, Beck J, Rydzynski K, Natarajan AT, Nilsson R: Micronucleus frequency in peripheral blood lymphocytes and buccal mucosa cells of copper smelter workers, with special regard to arsenic exposure. Int Arch Occup Env Health 2007, 80(5):371-380.
• [31]Zhong BZ, Gu ZW, Wallace WE, Whong WZ, Ong T: Genotoxicity of vanadium pentoxide in Chinese hamster V79 cells. Mutat Res 1994, 321(1–2):35-42.
• [32]Pfeiffer E, Gross K, Metzler M: Aneuploidogenic and clastogenic potential of the mycotoxins citrinin and patulin. Carcinogenesis 1998, 19(7):1313-1318.
• [33]Efthimiou M, Andrianopoulos C, Stephanou G, Demopoulos NA, Nikolaropoulos SS: Aneugenic potential of the nitrogen mustard analogues melphalan, chlorambucil and p-N, N-bis(2-chloroethyl)aminophenylacetic acid in cell cultures in vitro. Mutat Res 2007, 617(1–2):125-137.
• [34]Graf E: Antioxidant potential of ferulic acid. Free Radic Biol Med 1992, 13(4):435-448.
• [35]Rao CV, Desai D, Simi B, Kulkarni N, Amin S, Reddy BS: Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res 1993, 53(18):4182-4188.
• [36]Shimizu N, Naoe T, Kawazoe Y, Sakagami H, Nakashima H, Murakami T, Yamamoto N: Lignified materials as medicinal resources. VI. Anti-HIV activity of dehydrogenation polymer of p-coumaric acid, a synthetic lignin, in a quasi-in-vivo assay system as an intermediary step to clinical trials. Biol Pharm Bull 1993, 16(4):434-436.
• [37]Yu T, Yamaguchi H, Noshita T, Kidachi Y, Umetsu H, Ryoyama K: Selective cytotoxicity of glycyrrhetinic acid against tumorigenic r/m HM-SFME-1 cells: potential involvement of H-Ras downregulation. Toxicol Lett 2010, 192(3):425-430.
• [38]Son YO, Lee KY, Lee JC, Jang HS, Kim JG, Jeon YM, Jang YS: Selective antiproliferative and apoptotic effects of flavonoids purified from Rhus verniciflua Stokes on normal versus transformed hepatic cell lines. Toxicol Lett 2005, 155(1):115-125.
• [39]Tolbert PE, Shy CM, Allen JW: Micronuclei and other nuclear anomalies in buccal smears: methods development. Mutat Res 1992, 271(1):69-77.
• [40]Manelli-Oliveira R, Machado-Santelli GM: Cytoskeletal and nuclear alterations in human lung tumor cells: a confocal microscope study. Histochem Cell Biol 2001, 115(5):403-411.
• [41]Ekmekcioglu C, Feyertag J, Marktl W: Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2 cells. Cancer Lett 1998, 128(2):137-144.
• [42]Opdyke DL: Monographs on fragrance raw materials. Food Cosmet Toxicol 1975, 13(4):449-457.
• [43]Lee YJ, Liao PH, Chen WK, Yang CY: Preferential cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells. Cancer Lett 2000, 153(1–2):51-56.
• [44]Nakayama T, Yamada M, Osawa T, Kawakishi S: Inhibitory effects of caffeic acid ethyl ester on H2O2-induced cytotoxicity and DNA single-strand breaks in Chinese hamster V79 cells. Biosci Biotechnol Biochem 1996, 60(2):316-318.
• [45]Miller MC 3rd, Johnson KR, Willingham MC, Fan W: Apoptotic cell death induced by baccatin III, a precursor of paclitaxel, may occur without G(2)/M arrest. Cancer Chemother Pharmacol 1999, 44(6):444-452.
• [46]Gajate C, Barasoain I, Andreu JM, Mollinedo F: Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl)-2,4,6-cycloheptatrien-1 -one: protection by Bcl-2 and Bcl-X(L) and cell cycle arrest. Cancer Res 2000, 60(10):2651-2659.
• [47]Cotter TG, Lennon SV, Glynn JM, Green DR: Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res 1992, 52(4):997-1005.
• [48]Corfe BM, Dive C, Garrod DR: Changes in intercellular junctions during apoptosis precede nuclear condensation or phosphatidylserine exposure on the cell surface. Cell Death Differ 2000, 7(2):234-235.
• [49]Bar PR: Apoptosis–the cell’s silent exit. Life Sci 1996, 59(5–6):369-378.
• [50]Villa PG, Henzel WJ, Sensenbrenner M, Henderson CE, Pettmann B: Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J Cell Sci 1998, 111(Pt 6):713-722.
• [51]Boggio RF, Freitas VM, Cassiola FM, Urabayashi M, Machado-Santelli GM: Effect of a calcium-channel blocker (verapamil) on the morphology, cytoskeleton and collagenase activity of human skin fibroblasts. Burns 2011, 37(4):616-625.
• [52]Rosenblum MD, Shivers RR: ‘Rings’ of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere. Comp Biochem Physiol C Toxicol Pharmacol 2000, 125(1):121-131.
• [53]Mills JC, Stone NL, Pittman RN: Extranuclear apoptosis. The role of the cytoplasm in the execution phase. J Cell Biol 1999, 146(4):703-708.
• [54]Cima F, Ballarin L: Tributyltin induces cytoskeletal alterations in the colonial ascidian Botryllus schlosseri phagocytes via interaction with calmodulin. Aquat Toxicol 2000, 48(4):419-429.
• [55]Milas L, Hunter NR, Kurdoglu B, Mason KA, Meyn RE, Stephens LC, Peters LJ: Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol 1995, 35(4):297-303.
• [56]Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L: Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996, 56(4):816-825.
• [57]Tseng CJ, Wang YJ, Liang YC, Jeng JH, Lee WS, Lin JK, Chen CH, Liu IC, Ho YS: Microtubule damaging agents induce apoptosis in HL 60 cells and G2/M cell cycle arrest in HT 29 cells. Toxicology 2002, 175(1–3):123-142.
• [58]Chen N, Gong J, Chen X, Xu M, Huang Y, Wang L, Geng N, Zhou Q: Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA. Melanoma Res 2009, 19(2):87-93.
• [59]Chang SH, Worley LA, Onken MD, Harbour JW: Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res 2008, 18(3):191-200.
• [60]Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91(4):479-489.
• [61]Budihardjo I, Oliver H, Lutter M, Luo X, Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999, 15:269-290.
• [62]She QB, Chen N, Dong Z: ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J Biol Chem 2000, 275(27):20444-20449.
• [63]She QB, Bode AM, Ma WY, Chen NY, Dong Z: Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 2001, 61(4):1604-1610.
• [64]Hegarat LL, Orsiere T, Botta A, Fessard V: Okadaic acid: chromosomal non-disjunction analysis in human lymphocytes and study of aneugenic pathway in CHO-K1 cells. Mutat Res 2005, 578(1–2):53-63.
• [65]Chen H, Rupa DS, Tomar R, Eastmond DA: Chromosomal loss and breakage in mouse bone marrow and spleen cells exposed to benzene in vivo. Cancer Res 1994, 54(13):3533-3539.